Introduction

Screens the preclinical literature against prespecified criteria and summarises reported residence time and tolerability endpoints.

The typeset body for this sample record is limited to the front matter needed to review the article page. A complete IMRaD specimen, including figures, a table, an equation and references, is on the lipid-nanoparticle research article in this issue.